Skip to main navigation Skip to search Skip to main content

Phase II trial of induction immunotherapy with anti-PD-L1 for PD-L1 positive patients with unresectable stage IIIA and IIIB NSCLC eligible for chemoradiotherapy with curative intent

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date10/12/17 → 10/11/23

Funding

  • Alliance Foundation Trials LLC: $100,420.00